NDC:59338-775-01活性物质:FERUMOXYTOL剂量:510 mg/ 17 mL服用方式:静脉注射NDA:NDA022180 首次上市时间:07/13/2009分销商:AMAG Pharmaceuticals, Inc.生产商一:Baxter Pharmaceutical Solutions生产商二:Patheon Manufacturing Services LLC说明书:PDF
药品名: ABILIFY MAINTENA KIT (ARIPIPRAZOLE) ANDA: NDA #202971 NDC:59148-019-71 制造公司: OTSUKA PHARM CO LTD 活性物质: ARIPIPRAZOLE 剂量: 400MG/VIAL 使用方式: FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 营销状态: Prescription 批准日期: 10/08/2014批准类型: Approval ...
产品名称:SYMBICORT AEROSPHERE上市时间:04/28/2023NDA/ANDA/BLA:216579持证商:ASTRAZENECANDC:0310-2009-12说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216579s000lbl.pdf批准信:
产品名称:VIGABATRIN上市时间:04/28/2023NDA/ANDA/BLA:215519持证商:PROPEL PHARMANDC:说明书:批准信:
产品名称:DOLUTEGRAVIR上市时间:04/28/2023NDA/ANDA/BLA:215319持证商:LAURUS GENERICS INCNDC:说明书:批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215319Orig1s000TAltr.pdf
产品名称:LIQREV上市时间:04/28/2023NDA/ANDA/BLA:214952持证商:CMP DEV LLCNDC:46287-055-01说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214952s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214952Orig1s000ltr.pdf
产品名称:VEKLURY上市时间:04/28/2023NDA/ANDA/BLA:214787持证商:GILEAD SCIENCES INCNDC:61958-2902-2,61958-2901-2说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214787Orig1s000lbl.pdf批准信:https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/214787Orig1s000ltr.pdf
产品名称:DEFERASIROX上市时间:04/28/2023NDA/ANDA/BLA:214559持证商:AUCTANDC:42806-371-30,42806-372-30,42806-373-30,72647-371-30,72647-372-30,72647-373-30说明书:批准信:
产品名称:UZEDY上市时间:04/28/2023NDA/ANDA/BLA:213586持证商:TEVANDC:51759-305-10,51759-305-11,51759-410-10,51759-410-11,51759-520-10,51759-520-11,51759-630-10,51759-630-11,51759-740-10,51759-740-11,51759-850-10,51759-850-11,51759-960-10,51759-960-11说明书:https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/2...
产品名称:OMEPRAZOLE MAGNESIUM上市时间:04/28/2023NDA/ANDA/BLA:213201持证商:AUROBINDO PHARMA LTDNDC:58602-837-05说明书:批准信:
产品名称:BENDAMUSTINE HYDROCHLORIDE上市时间:04/28/2023NDA/ANDA/BLA:204104持证商:MYLAN LABS LTDNDC:说明书:批准信:
产品名称:NITROFURANTOIN上市时间:04/28/2023NDA/ANDA/BLA:201679持证商:AMNEAL PHARMSNDC:65162-689-88说明书:批准信: